Translational Frontiers: Insight From Lymphatics in Skin Regeneration

    February 2024 in “ Frontiers in physiology
    Yujia Jiang, Mirna Pérez‐Moreno
    Image of study
    TLDR Lymphatic vessels are important for skin repair and could affect skin disease treatments.
    Recent studies have revealed the significant role of lymphatic vessels in skin regeneration, a process previously known for its complexity and importance in repairing the skin and understanding dermatological conditions. Lymphatic vessels, once thought to be solely involved in fluid balance and immune response, are now seen as key players in interacting with skin stem cells to facilitate skin repair. This Mini Review summarizes the latest findings in the field, emphasizing the interaction between stem cells and lymphatic vessels in skin regeneration. It also discusses new translational approaches that could impact the treatment of skin diseases, highlights current research gaps, and suggests directions for future research in this rapidly developing area.
    Discuss this study in the Community →

    Research cited in this study

    17 / 17 results

    Related Community Posts Join

    6 / 6 results

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  44 upvotes 4 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

      community 4 months on 2.5 mg OM, no improvement

      in Minoxidil  6 upvotes 1 year ago
      After 4 months on oral minoxidil with no significant hair regrowth, a user is frustrated and considering alternative treatments since they can't take finasteride due to side effects. Suggestions include natural DHT blockers, lifestyle changes, and other hair care tips.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 1 year ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

    Related Research

    1 / 1 results